Healthcare Industry News: Johnson & Johnson
News Release - February 14, 2014
Bioventus Names Allison London Brown New VP of Global MarketingDURHAM, N.C.--(Healthcare Sales & Marketing Network)--Bioventus, a leader in active orthopedic healing, today announced that Allison London Brown has joined the company as its new Vice President of Global Marketing. London Brown is based in the company’s Durham headquarters and reports directly to Bioventus CEO Anthony Bihl.
In the role, London Brown is responsible for developing global strategic marketing plans, including evaluating new market opportunities, and for management of the current product portfolio. She oversees the tactical implementation of U.S. and International marketing plans, including product positioning, product launch planning and sales support. She also provides leadership for business strategy, external communications, professional affairs and medical education.
“Allison comes to Bioventus with a wealth of experience – not only in marketing, but also as a former CEO and COO of healthcare organizations,” Bihl said. “She is known for building brands and driving revenue in the medical device, technology and pharmaceutical industries. I’m excited to have her on our leadership team.”
During London Brown’s 17-year career, she has launched more than 80 new products, brands and services for leading global healthcare companies. She worked for 10 years at the Johnson & Johnson family of companies, two years at GE Healthcare and two years at Healthways Inc. Her most recent experience includes CEO of Aegis Women’s Health Technologies, Chief Operating Officer/Chief Commercial Officer at Stanley Healthcare Solutions (division of Stanley/Black & Decker), and a Senior Advisor, Board Member and Co-Founder of various start-up companies.
London Brown is also a published author, accomplished presenter and holder of five patents. She holds a Bachelor of Science from Auburn University, a Masters of Science from North Carolina State University and a Masters of Business Administration with Honors from Temple University.
Bioventus is a biologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. The company’s innovative products include market-leading devices, therapies and diagnostics that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine, and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com or follow the company on Facebook (www.facebook.com/bioventus) or Twitter (@BioventusGlobal or www.twitter.com/BioventusGlobal).
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.